Key Financial Data Of Group

Carna Biosciences, Inc. - Filing #7586726

Concept As at
2022-09-30
2022-07-01 to
2022-09-30
2022-01-01 to
2022-09-30
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-09-30
2021-01-01 to
2021-09-30
2021-07-01 to
2021-09-30
Key financial data of group
Business results of group
Net sales
1,095,607,000 JPY
2,017,529,000 JPY
636,512,000 JPY
Ordinary profit (loss)
-735,543,000 JPY
-522,992,000 JPY
-1,171,814,000 JPY
Profit (loss) attributable to owners of parent
-795,218,000 JPY
-534,474,000 JPY
-1,178,075,000 JPY
Comprehensive income
-718,777,000 JPY
-510,976,000 JPY
-1,162,265,000 JPY
Net assets
3,943,268,000 JPY
4,315,572,000 JPY
3,479,725,000 JPY
Total assets
4,547,738,000 JPY
5,432,560,000 JPY
4,211,341,000 JPY
Basic earnings (loss) per share
-31.92
-58.56
-42.10
-94.24
-31.68
Diluted earnings per share
Equity-to-asset ratio
0.865 xbrli:pure
0.793 xbrli:pure
0.824 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.